Baotou Dongbao Bio-Tech (300239)
- 5.07
- +0.02+0.40%
Baotou Dongbao Bio-Tech (300239) News
Express News | Dongbao Bio-Tech: The company's collagen products can be used as specialized process additives in the production of electrolytic copper foil.
Dongbao Bio stated on an interactive platform that the company primarily produces a series of products including gelatin, collagen, and empty capsules, and does not directly manufacture electrolytic copper foil finished goods. Its collagen products can be used as specialized process additives in electrolytic copper foil production. These related products have already been applied in the market, and both sales volume and revenue from this segment saw year-over-year growth in 2025. This represents an emerging business line that the company continues to expand, although it currently contributes only a small portion of total revenue.
Gelatin Market Worth $6.43 Billion by 2031- Exclusive Report by MarketsandMarkets
DELRAY BEACH, Fla., June 19, 2026 /PRNewswire/ -- According to MarketsandMarkets, the gelatin market is estimated at USD 4.59 billion in 2026 and is projected to reach USD 6.43 billion by 2031, at a
Baotou Dongbao Bio-Tech: First Quarter Report 2026
Dongbao Bio (300239.SZ) announced its Q1 financial results, with a net profit attributable to shareholders of 19.6941 million yuan, representing a 3.41% increase.
Dongbao Bio (300239.SZ) released its first-quarter report for 2026, with operating revenue of 191 million yuan. The net profit attributable to shareholders of the listed company was 19.6941 million yuan, representing a year-on-year increase of 3.41%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 17.299 million yuan, reflecting a year-on-year decrease of 2.60%. The basic earnings per share were 0.0332 yuan.
Dongbao Bio (300239.SZ): Q1 net profit of 19.69 million yuan, up 3.41% year-on-year
Gelonghui, April 23rd: Dongbao Bio (300239.SZ) released its Q1 report, showing operating revenue of 190 million yuan, a year-on-year increase of 1.32%. Net profit attributable to shareholders of the listed company amounted to 19.69 million yuan, growing by 3.41% year-on-year. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 17.299 million yuan, representing a year-on-year decrease of 2.60%.
The Inner Mongolia Free Trade Zone in the A-share market has been officially approved, with related concept stocks showing strong activity. Mengcao Ecology surged over 14%.
Gelonghui, April 10 | Inner Mongolia concept stocks in the A-share market collectively surged. Among them, Mengcao Ecology rose over 14%, Oujing Technology hit a 10CM limit-up, Qishi Dairy increased by more than 8%, Datang Pharmaceuticals, Neimenggu Xinhua, and Dazhong Mining rose over 6%, Yinsite increased by over 4%, and Dongbao Bio, Jinmei Technology, and Neimenggu Yiji rose over 3%. In terms of news, the State Council recently released the 'Overall Plan for the China (Inner Mongolia) Pilot Free Trade Zone' on April 9. The 'Overall Plan' grants the Inner Mongolia Free Trade Zone greater autonomy in reform, encouraging pilot initiatives to explore original, integrated, and differentiated reforms in broader areas and at deeper levels.
Dongbao Biological: 2025 Annual Report
Dongbao Biological: Summary of the 2025 Annual Report